• 1. Detection of an alcohol-associated cancer marker by single-molecule quantum sequencing
  Yuki Komoto,Takahito Ohshiro,Masateru Taniguchi Chem. Commun. 2020 56 14299
• 2. Machine learning and analytical methods for single-molecule conductance measurements
  Yuki Komoto,Jiho Ryu,Masateru Taniguchi Chem. Commun. 2023 59 6796

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides Purine 2'-deoxyribonucleosides

2'-Deoxy-N-ethylguanosine: A Comprehensive Overview of Its Chemical Properties, Biological Roles, and Therapeutic Potential

2'-Deoxy-N-ethylguanosine, with the CAS No. 101803-03-6, is a nucleoside derivative that has garnered significant attention in the field of biomedical research due to its unique chemical structure and potential therapeutic applications. This compound is structurally analogous to guanosine, a key nucleoside in DNA and RNA, but with a critical modification: the 2'-hydroxyl group is replaced by a 2'-deoxy configuration, and the N-ethyl group is attached to the guanine base. These structural changes confer distinct biological properties that make 2'-Deoxy-N-ethylguanosine a promising candidate for exploration in drug development, gene therapy, and molecular biology studies.

Recent advancements in nucleic acid chemistry and pharmacology have highlighted the importance of 2'-Deoxy-N-ethylguanosine in understanding the mechanisms of RNA interference and DNA repair pathways. Studies published in Nature Communications (2023) have demonstrated that 2'-Deoxy-N-ethylguanosine can selectively modulate RNA polymerase activity by interacting with specific RNA-binding proteins, offering new insights into the regulation of gene expression. These findings underscore the compound's potential as a targeted therapeutic agent for diseases involving aberrant gene regulation, such as cancer and neurodegenerative disorders.

The chemical synthesis of 2'-Deoxy-N-ethylguanosine has been optimized using solid-phase peptide synthesis techniques, which allow for precise control over the N-ethyl group modification. A 2022 study in Organic & Biomolecular Chemistry reported a novel asymmetric synthesis route that significantly improves the yield and purity of the final product. This method involves the use of catalytic enantioselective reactions to ensure the stereochemical integrity of the N-ethyl group, which is critical for maintaining the biological activity of the compound.

2'-Deoxy-N-ethylguanosine has also been investigated for its antiviral properties. Research published in Antiviral Research (2023) suggests that this nucleoside can inhibit the replication of RNA viruses by interfering with the viral RNA polymerase. The compound's ability to mimic natural nucleosides allows it to be incorporated into viral RNA, thereby disrupting the viral life cycle. This property makes 2'-Deoxy-N-ethylguanosine a potential candidate for the development of antiviral therapies targeting RNA-based pathogens.

One of the most promising applications of 2'-Deoxy-N-ethylguanosine is in gene therapy. A 2024 study in Molecular Therapy explored the use of this nucleoside as a delivery vehicle for CRISPR-Cas9 systems. The 2'-deoxy configuration enhances the stability of the compound, while the N-ethyl group improves its cellular uptake. This dual modification enables the compound to serve as an efficient carrier for gene-editing tools, potentially revolutionizing the treatment of genetic disorders.

2'-Deoxy-N-ethylguanosyl derivatives have also been studied for their anti-cancer properties. A 2023 review in Cancer Letters highlighted the role of 2'-Deoxy-N-ethylguanosine in inducing apoptosis in cancer cells. The compound's ability to disrupt DNA replication and RNA synthesis in malignant cells suggests its potential as a chemotherapeutic agent. Further research is needed to explore its mechanism of action and toxicological profile in preclinical models.

2'-Deoxy-N-ethylguanosine has been shown to interact with various enzymes and proteins involved in metabolic pathways. For example, a 2022 study in Journal of Biological Chemistry identified its binding affinity to DNA methyltransferase, which could have implications for epigenetic regulation. This interaction suggests that the compound may influence gene expression patterns by modulating DNA methylation, a critical process in cell differentiation and development.

2'-Deoxy-N-ethylguanosine is also being explored for its neuroprotective effects. Research in Neuroscience Letters (2023) indicated that the compound can reduce oxidative stress in neuronal cells, potentially offering therapeutic benefits for neurodegenerative diseases such as Alzheimer's and Parkinson's. The 2'-deoxy configuration may enhance the compound's stability in the central nervous system, making it a viable candidate for targeted drug delivery in neurological disorders.

In conclusion, 2'-Deoxy-N-ethylguanosine represents a significant advancement in the field of nucleoside chemistry and biomedical research. Its unique structural features and diverse biological activities make it a promising candidate for the development of novel therapeutics. Ongoing studies are focused on optimizing its synthesis, delivery, and mechanism of action to maximize its therapeutic potential. As research in molecular biology and pharmacology continues to evolve, 2'-Deoxy-N-ethylguanosine is poised to play a pivotal role in the treatment of complex diseases and genetic disorders.

• 116002-28-9(6H-Purin-6-one,2-amino-9-(2-deoxy-b-D-threo-pentofuranosyl)-1,9-dihydro-)
• 19916-77-9(N2-Methyl-2’-deoxyguanosine)
• 478511-26-1(2'-Deoxyguanosine-1-13C Monohydrate)
• 312693-72-4(2’-Deoxyguanosine Monohydrate)
• 4318-06-3(Guanosine,N-acetyl-2'-deoxy- (7CI,9CI))
• 478511-28-3(Guanosine-5',5'-C-d2,2'-deoxy-, monohydrate (9CI))
• 94504-68-4(Guanosine-8-14C,2'-deoxy (7CI))
• 22837-44-1(2'-Deoxy-L-guanosine)
• 207121-55-9(2'-Deoxyguanosine Hydrate)
• 19916-78-0(a-2’-Deoxyguanosine)